Literature DB >> 24666639

Role of non-coding RNAs in pancreatic beta-cell development and physiology.

L Eliasson1, J L S Esguerra.   

Abstract

The progression of diabetes is accompanied by increasing demand to the beta-cells to produce and secrete more insulin, requiring complex beta-cell adaptations. Functionally active and ubiquitous non-coding RNAs (ncRNAs) have the capacity to take part in such adaptations as they have been shown to be key regulatory molecules in various biological processes. In the pancreatic islets, the function of ncRNAs and their contribution to disease development is beginning to be understood. Here, we review the different classes of ncRNAs, such as long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), and their potential contribution to insulin secretion. A special focus will be on miRNAs and their regulatory function in beta-cell physiology and insulin exocytosis. As important players in gene regulation, ncRNAs have huge potential in opening innovative therapeutic avenues against diabetes and associated complications.
© 2014 Scandinavian Physiological Society. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  diabetes; exocytosis; insulin biosynthesis; insulin secretion; microRNA; non-coding RNA

Mesh:

Substances:

Year:  2014        PMID: 24666639     DOI: 10.1111/apha.12285

Source DB:  PubMed          Journal:  Acta Physiol (Oxf)        ISSN: 1748-1708            Impact factor:   6.311


  37 in total

Review 1.  Genes affecting β-cell function in type 1 diabetes.

Authors:  Tina Fløyel; Simranjeet Kaur; Flemming Pociot
Journal:  Curr Diab Rep       Date:  2015-11       Impact factor: 4.810

2.  PIWI-interacting RNAs as novel regulators of pancreatic beta cell function.

Authors:  Imène Sarah Henaoui; Cécile Jacovetti; Inês Guerra Mollet; Claudiane Guay; Jonathan Sobel; Lena Eliasson; Romano Regazzi
Journal:  Diabetologia       Date:  2017-07-16       Impact factor: 10.122

Review 3.  MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases.

Authors:  Akiko Matsuda; Irene K Yan; Catherine Foye; Mansi Parasramka; Tushar Patel
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2016-08-01       Impact factor: 4.690

4.  Contribution of Intronic miR-338-3p and Its Hosting Gene AATK to Compensatory β-Cell Mass Expansion.

Authors:  Cécile Jacovetti; Veronica Jimenez; Eduard Ayuso; Ross Laybutt; Marie-Line Peyot; Marc Prentki; Fatima Bosch; Romano Regazzi
Journal:  Mol Endocrinol       Date:  2015-03-09

Review 5.  Dysregulated expression of long noncoding RNAs serves as diagnostic biomarkers of type 2 diabetes mellitus.

Authors:  Weiyue Zhang; Juan Zheng; Xiang Hu; Lulu Chen
Journal:  Endocrine       Date:  2019-07-25       Impact factor: 3.633

6.  Cross-talks between microRNAs and mRNAs in pancreatic tissues of streptozotocin-induced type 1 diabetic mice.

Authors:  Caiming Tian; Xiaoxi Ouyang; Qing Lv; Yaou Zhang; Weidong Xie
Journal:  Biomed Rep       Date:  2015-02-12

Review 7.  Beyond the Protein-Coding Sequence: Noncoding RNAs in the Pathogenesis of Type 2 Diabetes.

Authors:  Johanna K DiStefano
Journal:  Rev Diabet Stud       Date:  2016-01-28

Review 8.  Noncoding RNAs in β cell biology.

Authors:  Ruth A Singer; Luis Arnes; Lori Sussel
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2015-04       Impact factor: 3.243

Review 9.  Lnc-ing non-coding RNAs with metabolism and diabetes: roles of lncRNAs.

Authors:  Neha Goyal; Devesh Kesharwani; Malabika Datta
Journal:  Cell Mol Life Sci       Date:  2018-01-31       Impact factor: 9.261

Review 10.  RNA interference-based therapy and its delivery systems.

Authors:  Xiuhui Chen; Lingegowda S Mangala; Cristian Rodriguez-Aguayo; Xianchao Kong; Gabriel Lopez-Berestein; Anil K Sood
Journal:  Cancer Metastasis Rev       Date:  2018-03       Impact factor: 9.264

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.